SENSEX NIFTY
Feb 14, 2013, 02.09 PM IST | Source: Reuters

Dr Reddy's falls on concerns Q3 results may miss estimates

Shares in Dr Reddy's Laboratories fall 2.1 percent on worries the drug maker will post lower-than-expected October-December earnings, due later in the day

Dr Reddy's falls on concerns Q3 results may miss estimates

Shares in Dr Reddy's Laboratories fall 2.1 percent on worries the drug maker will post lower-than-expected October-December earnings, due later in the day.

Margins are also expected to see significant erosion, several dealers add.

Dr Reddy's could miss consensus earnings per share (EPS) estimates by 6 percent in the October-December quarter, according to Thomson Reuters StarMine SmartEstimate data, which measures the forecasts from top-ranked analysts against wider forecasts. * StarMine SmartEstimate suggests EPS for the quarter ending December at Rs 26.03 compared with mean estimate of Rs 27.89.

Dr Reddys Labs stock price

On July 24, 2014, Dr Reddys Laboratories closed at Rs 2710.55, down Rs 23.4, or 0.86 percent. The 52-week high of the share was Rs 2939.80 and the 52-week low was Rs 2025.00.


The company's trailing 12-month (TTM) EPS was at Rs 113.47 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 23.89. The latest book value of the company is Rs 547.69 per share. At current value, the price-to-book value of the company is 4.95.

Set email alert for

ADS BY GOOGLE

video of the day

Market in fine fettle; 2014-end Sensex target at 26300:Citi

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.